NCT07607678
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07607678
Title A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Yale Cancer Center NOT_YET_RECRUITING New Haven Connecticut 06511 United States Details
Hackensack University Medical Center NOT_YET_RECRUITING Hackensack New Jersey 07601 United States Details
New York University Langone Medical Center NOT_YET_RECRUITING New York New York 10016 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
National Cancer Center Hospital East RECRUITING Chiba, Kashiwa 277-8577 Japan Details
National Cancer Center Hospital RECRUITING Tokyo, Chuo-ku 104-0045 Japan Details
Hospital Universitari Vall d'Hebron RECRUITING Barcelona 08035 Spain Details
Clínica Universidad de Navarra RECRUITING Pamplona 31008 Spain Details
Hospital Clinico Universitario de Valencia RECRUITING Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field